Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Proc Natl Acad Sci U S A. 2022 Apr 5;119(14):e2117112119. doi: 10.1073/pnas.2117112119. Epub 2022 Mar 28.
SignificanceSTAT3 (signal transducer and activator of transcription 3) is a master transcription factor that organizes cellular responses to cytokines and growth factors and is implicated in inflammatory disorders. STAT3 is a well-recognized therapeutic target for human cancer and inflammatory disorders, but how its function is regulated in a cell type-specific manner has been a major outstanding question. We discovered that Stat3 imposes self-directed regulation through controlling transcription of its own regulator homeodomain-interacting protein kinase 2 () in a T helper 17 (Th17) cell-specific manner. Our validation of the functional importance of the Stat3-Hipk2 axis in Th17 cell development in the pathogenesis of T cell-induced colitis in mice suggests an approach to therapeutically treat inflammatory bowel diseases that currently lack a safe and effective therapy.
信号转导子和转录激活子 3(STAT3)是一种主转录因子,它组织细胞对细胞因子和生长因子的反应,并且与炎症性疾病有关。STAT3 是人类癌症和炎症性疾病的一个公认的治疗靶点,但它的功能如何以细胞类型特异性的方式进行调节一直是一个主要的悬而未决的问题。我们发现 Stat3 通过以 Th17 细胞特异性的方式控制其自身调节因子同源域相互作用蛋白激酶 2(Hipk2)的转录,对自身施加自我导向的调节。我们验证了 Stat3-Hipk2 轴在小鼠 T 细胞诱导结肠炎发病机制中的 Th17 细胞发育中的功能重要性,这表明了一种治疗炎症性肠病的方法,目前这种疾病缺乏安全有效的治疗方法。